Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Colorectal carcinomas exhibit varying prognoses linked to specific Ki-Ras mutations.
• The Ki-Ras G12V mutation correlates with higher cancer stage and lethality.
• The Ki-Ras G12D mutation lacks this adverse prognostic association.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the differential prognostic significance of Ki-Ras G12V and G12D mutations in colorectal cancer.
• To explore how altered GTPase activity and nucleotide binding affinity influence Ras signaling and oncogenic potential.

Main Methods:

• Analysis of GTPase activity for wild-type (WT), G12V, and G12D Ras proteins.
• Assessment of GTP analogue (GppNp) binding affinities to different Ras variants.
• Structural comparisons of Ras mutations to understand effector interactions.
• Evaluation of GTPase-activating protein (GAP) interactions.

Main Results:

• G12V Ras exhibits significantly lower GTPase activity compared to G12D Ras and WT Ras.
• G12D Ras shows an 8-fold weaker binding affinity for GppNp, potentially due to electrostatic repulsion impacting GTP binding.
• G12V Ras binds GTP more tightly, suggesting a more persistent oncogenic signal compared to G12D Ras.
• Structural differences in the Switch I region may alter downstream signaling molecule interactions.

Conclusions:

• The distinct GTP binding properties of G12V and G12D Ras mutations likely explain their differing impacts on colorectal cancer prognosis.
• G12V Ras's enhanced GTP affinity promotes a sustained oncogenic signal, contributing to poorer outcomes.
• These findings highlight the importance of specific Ras mutations in determining carcinogenic potential and clinical significance.